摘要
目的:对中线T细胞淋巴瘤的克隆性进行研究。方法:用一组针对T细胞受体γ链基因V区片段的家族特异性引物和PCR方法,对11例(22个标本)中线T细胞淋巴瘤病例进行了T细胞受体丁基因重排的检测。结果:22个标本中21个有T细胞受体γ链基因的克隆性重排(94.45%)。在9例原发灶的连续活检和1例原发灶及其转移灶的标本中均未发现增生的克隆家族的改变。结论:中线T细胞淋巴瘤的病变组织中存在T细胞的单克隆性增生,为该肿瘤的T细胞起源提供了分子生物学的证据。在中线T细胞淋巴瘤的疾病过程中(包括转移灶)增生T细胞的家族未发生变化,支持肿瘤的单克隆起源学说。
Objective: To investigate the clonality of midline T-cell lymphoma.Methods: Using polymerase chain reaction method and a panel of family specific primers for the variable regions of TCR- γgene, and totally 11 cases(22 samples) of midline T-cell lymphoma(idline malignant reticulosis) were studied.Results: Family specific monoclonal TCR-γgene rearrangements were found in 21 out of 22 samples(94.45%). There was no change of clonality during the course of disease. Conclusion: There is monoclonal T-cell proliferation in midline T-cell lymphoma and the clonality is not transformed with the advance of the disease. This finding provides an evidence to support the hypothesis of monoclonal origin of neoplasm.
基金
国家自然科学基金资助(基金编号39100047)
美国中华医学基金会部分资助(基金编号9315)
关键词
T细胞淋巴瘤
聚合酶链反应
基因重排
Lymphoma, T-Cell
Polymerase chain reaction
Receptors, antigen, t-cell
Gene rearrangement, t-lymphocyte